Cantor Fitzgerald Reaffirms Overweight Rating for Intellia Therapeutics (NASDAQ:NTLA)
Cantor Fitzgerald restated their overweight rating on shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $65.00 target price on the stock. A number of other brokerages have also issued reports on NTLA. Wedbush reiterated a neutral rating and set a […]
More Stories
Marriott International, Inc. (NASDAQ:MAR) Insider Sells $485,300.10 in Stock
Marriott International, Inc. (NASDAQ:MAR – Get Free Report) insider William P. Brown sold 1,707 shares of Marriott International stock in...
Insider Selling: Vericel Co. (NASDAQ:VCEL) Director Sells 2,500 Shares of Stock
Vericel Co. (NASDAQ:VCEL – Get Free Report) Director Robert L. Md Zerbe sold 2,500 shares of the business’s stock in...
CMS Energy Co. (NYSE:CMS) CAO Sells $64,116.00 in Stock
CMS Energy Co. (NYSE:CMS – Get Free Report) CAO Scott B. Mcintosh sold 936 shares of the business’s stock in...
Insider Selling: Hilton Grand Vacations Inc. (NYSE:HGV) Insider Sells $2,052,112.95 in Stock
Hilton Grand Vacations Inc. (NYSE:HGV – Get Free Report) insider Charles R. Jr. Corbin sold 49,389 shares of the firm’s...
Primerica (NYSE:PRI) Hits New 12-Month High – Still a Buy?
Primerica, Inc. (NYSE:PRI – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday ....
Tompkins Financial (NYSEAMERICAN:TMP) Reaches New 12-Month High – Here’s Why
Tompkins Financial Co. (NYSEAMERICAN:TMP – Get Free Report)’s share price hit a new 52-week high during trading on Monday ....